Pamapimod
Get a Quick Quote Now
Select Packaging
Product Description
Product
Pamapimod
CAS
449811-01-2
Formula
C19H20F2N4O4
Synonym
Pamapimod, 449811-01-2, RO 4402257, R1503, PamapimodR-1503, Ro4402257, Ro-4402257, CHEMBL1090089, CHEBI:90685, R-1503, 8S2C9V11K4, 6-(2,4-Difluorophenoxy)-2-{[3-Hydroxy-1-(2-Hydroxyethyl)propyl]amino}-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One, Pamapimod (R-1503, Ro4402257), 6-(2,4-difluorophenoxy)-2-(1,5-dihydroxypentan-3-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one, 6-(2,4-Difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, Pamapimod [USAN], Pamapimod [USAN:INN], UNII-8S2C9V11K4, 6-(2,4-Difluorophenoxy)-2-((1,5-dihydroxypentan-3-yl)amino)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, 6-(2,4-Difluorophenoxy)-2-((3-hydroxy-1-(2-hydroxyethyl)propyl)amino)-8-methylpyrido(2,3-d)pyrimidin-7(8H)-one, 6-(2,4-difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, PAMAPIMOD [INN], Pamapimod (INN/USAN), R 1503, PAMAPIMOD [WHO-DD], GTPL9915, SCHEMBL3636701, DTXSID90963312, BCP17491, EX-A1084, BDBM50314070, MFCD25976551, s8125, CCG-268715, CS-5965, compound 2b [PMID: 21375264], AC-33182, AS-56094, HY-10405, FT-0673504, D08963, Q27162644, 6-(2,4-difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)amino]-8-methyl-7H,8H-pyrido[2,3-d]pyrimidin-7-one, 6-(2,4-Difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)imino]-8-methyl-2,8-dihydropyrido[2,3-d]pyrimidin-7(3H)-one, FLW, Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-(2,4-difluorophenoxy)-2-((3-hydroxy-1-(2-hydroxyethyl)propyl)amino)-8-methyl-
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Pamapimod is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Pamapimod
Product Description
Product
Pamapimod
CAS
449811-01-2
Formula
C19H20F2N4O4
Synonym
Pamapimod, 449811-01-2, RO 4402257, R1503, PamapimodR-1503, Ro4402257, Ro-4402257, CHEMBL1090089, CHEBI:90685, R-1503, 8S2C9V11K4, 6-(2,4-Difluorophenoxy)-2-{[3-Hydroxy-1-(2-Hydroxyethyl)propyl]amino}-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One, Pamapimod (R-1503, Ro4402257), 6-(2,4-difluorophenoxy)-2-(1,5-dihydroxypentan-3-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one, 6-(2,4-Difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, Pamapimod [USAN], Pamapimod [USAN:INN], UNII-8S2C9V11K4, 6-(2,4-Difluorophenoxy)-2-((1,5-dihydroxypentan-3-yl)amino)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, 6-(2,4-Difluorophenoxy)-2-((3-hydroxy-1-(2-hydroxyethyl)propyl)amino)-8-methylpyrido(2,3-d)pyrimidin-7(8H)-one, 6-(2,4-difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, PAMAPIMOD [INN], Pamapimod (INN/USAN), R 1503, PAMAPIMOD [WHO-DD], GTPL9915, SCHEMBL3636701, DTXSID90963312, BCP17491, EX-A1084, BDBM50314070, MFCD25976551, s8125, CCG-268715, CS-5965, compound 2b [PMID: 21375264], AC-33182, AS-56094, HY-10405, FT-0673504, D08963, Q27162644, 6-(2,4-difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)amino]-8-methyl-7H,8H-pyrido[2,3-d]pyrimidin-7-one, 6-(2,4-Difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)imino]-8-methyl-2,8-dihydropyrido[2,3-d]pyrimidin-7(3H)-one, FLW, Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-(2,4-difluorophenoxy)-2-((3-hydroxy-1-(2-hydroxyethyl)propyl)amino)-8-methyl-
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Pamapimod is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
